九天生物医药（上海）有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Skyline Therapeutics' Novel Gene Therapy SKG1108 Receives FDA Orphan Drug Designation for Retinitis Pigmentosa 2024-09-03 18:00
Skyline Therapeutics Receives FDA Clearance of IND for SKG0106, a Novel Intravitreally Delivered AAV Gene Therapy Candidate for Neovascular Age-related Macular Degeneration 2023-07-03 19:00
Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023 2023-05-17 18:00
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting 2023-05-03 12:00
1